Aemetis (NASDAQ:AMTX) Stock Price Passes Below 200-Day Moving Average - Time to Sell?

Aemetis, Inc. (NASDAQ:AMTX - Get Free Report)'s stock price passed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $3.33 and traded as low as $2.60. Aemetis shares last traded at $2.78, with a volume of 599,676 shares trading hands.

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on AMTX. Ascendiant Capital Markets dropped their price objective on Aemetis from $20.00 to $19.00 and set a "buy" rating on the stock in a report on Tuesday, September 3rd. HC Wainwright reaffirmed a "buy" rating and set a $28.00 price objective on shares of Aemetis in a research note on Friday, August 2nd. Truist Financial reaffirmed a "hold" rating and set a $3.50 target price (down previously from $4.00) on shares of Aemetis in a report on Wednesday, July 31st. StockNews.com raised shares of Aemetis to a "sell" rating in a report on Wednesday, July 31st. Finally, UBS Group decreased their price target on shares of Aemetis from $8.25 to $7.75 and set a "buy" rating on the stock in a report on Monday, August 19th. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating and four have given a buy rating to the company's stock. According to MarketBeat, Aemetis has an average rating of "Moderate Buy" and an average price target of $12.95.

Aemetis Stock Performance

The stock's 50 day simple moving average is $2.51 and its 200 day simple moving average is $3.31. The firm has a market cap of $123.43 million, a PE ratio of -2.38 and a beta of 1.24.

Aemetis (NASDAQ:AMTX - Get Free Report) last released its earnings results on Thursday, August 1st. The specialty chemicals company reported ($0.66) earnings per share for the quarter, missing analysts' consensus estimates of ($0.41) by ($0.25). The company had revenue of $66.56 million during the quarter, compared to the consensus estimate of $75.37 million. During the same period last year, the firm earned ($0.68) EPS. As a group, analysts anticipate that Aemetis, Inc. will post -2.07 earnings per share for the current year.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the company. SG Americas Securities LLC purchased a new stake in Aemetis during the 1st quarter valued at $60,000. State Board of Administration of Florida Retirement System purchased a new stake in shares of Aemetis during the first quarter worth about $84,000. Bank of New York Mellon Corp bought a new stake in shares of Aemetis in the second quarter worth about $306,000. Rhumbline Advisers increased its holdings in Aemetis by 2,837.1% during the 2nd quarter. Rhumbline Advisers now owns 52,309 shares of the specialty chemicals company's stock valued at $157,000 after purchasing an additional 50,528 shares during the period. Finally, Hutchinson Capital Management CA purchased a new position in Aemetis during the 2nd quarter valued at about $70,000. Institutional investors own 27.02% of the company's stock.

Aemetis Company Profile

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.